Related Experiment Videos
p53 Status and gene transfer experiments using CMV enhancer/promoter.
S Allamane1, D Ratel, P Jourdes
1INSERM U318, CHU Michallon, Grenoble cedex 09, 38043, France.
Biochemical and Biophysical Research Communications
|February 13, 2001
Summary
Transfection efficiency measurements can be skewed by cellular factors like p53 status, impacting gene therapy research. Distinguishing true transfection rates from reporter gene expression is crucial for accurate comparisons.
Area of Science:
- Molecular Biology
- Gene Therapy
- Cell Biology
Background:
- Transfection efficiency is critical for gene therapy, often assessed using reporter genes driven by the cytomegalovirus (CMV) promoter.
- Current methods may not account for how the transfection process itself affects promoter activity.
Purpose of the Study:
- To investigate the influence of cellular p53 status on transfection efficiency measurements.
- To differentiate between actual transfection rates and transgene transcription levels.
Main Methods:
- Utilized p53 null fibroblasts for transfection experiments.
- Employed reporter gene plasmids (pCMV-luc, pCMV-betagal) to assess transfection efficiency.
- Analyzed the impact of cellular p53 levels on reporter gene expression.
Main Results:
- Transfection efficiency, as measured by reporter gene expression, was significantly affected by the p53 status of the cells.
- Differences in cellular p53 levels can account for variations in observed transfection efficiencies across cell lines.
- The p53 protein influences the transcriptional activity of the CMV promoter.
Conclusions:
- Cellular p53 status is a critical variable affecting transfection efficiency assessments.
- Future comparisons of transfection efficiencies must differentiate between cellular uptake and transgene expression.
- The p53-mediated down-regulation of the CMV promoter needs consideration during vector design to prevent self-modulation of transgene expression.